Company: RPTX
Filing Date: 2025-06-17
Form Type: 8-K
Source: 0001193125-25-142045
Chunk: 0

Company: Repare Therapeutics Inc.
Filing Date: 2025-06-17
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07      Submission of Matters to a Vote of Security Holders.  

On June 17, 2025, Repare Therapeutics Inc., a corporation governed by the Business Corporations Act(Québec) (the “ Company”), held its 2025 Annual Meeting of Shareholders (“ Annual Meeting”), at which a quorum was present. At the Annual Meeting, the Company’s shareholders voted on the three proposals set forth below. A more detailed description of each proposal is set forth in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 29, 2025 (the “ Proxy Statement”).